Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients With Radiorecurrent Prostate Cancer

NCT00110526 is registered in ClinicalTrials.gov with Simon Hall as lead sponsor.

NCT NCT00110526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00110526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients With Radiorecurrent Prostate Cancer
Lead sponsor
Simon Hall
Phase
Phase 1
Overall status
Withdrawn
Start date
April 30, 2005
Completion date
April 30, 2008
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm recurrence, local, prostatic neoplasms